Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER)Moehler, M. ; Maderer, A. ; Thuss-Patience, P.C. ; Brenner, B. ; Meiler, J. ; Ettrich, T.J. ; Hofheinz, R.-D. ; Al-Batran, S.E. ; Vogel, A. ; Mueller, L. ; Lutz, M.P. ; Lordick, F. ; Alsina, M. ; Borchert, K. ; Greil, R. ; Eisterer, W. ; Schad, A. ; Slotta-Huspenina, J. ; Van Cutsem, E. ; Lorenzen, S.Annals of oncology, 2020-02, Vol.31 (2), p.228-235 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
2 |
Material Type: Artigo
|
Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM studyFolprecht, G. ; Pericay, C. ; Saunders, M.P. ; Thomas, A. ; Lopez Lopez, R. ; Roh, J.K. ; Chistyakov, V. ; Höhler, T. ; Kim, J.-S. ; Hofheinz, R.-D. ; Ackland, S.P. ; Swinson, D. ; Kopp, M. ; Udovitsa, D. ; Hall, M. ; Iveson, T. ; Vogel, A. ; Zalcberg, J.R.Annals of oncology, 2016-07, Vol.27 (7), p.1273-1279 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
3 |
Material Type: Artigo
|
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel±darbepoetin alfa in primary breast cancer—results at the time of surgeryUntch, M. ; Fasching, P.A. ; Konecny, G.E. ; von Koch, F. ; Conrad, U. ; Fett, W. ; Kurzeder, C. ; Lück, H.-J. ; Stickeler, E. ; Urbaczyk, H. ; Liedtke, B. ; Salat, C. ; Harbeck, N. ; Müller, V. ; Schmidt, M. ; Hasmüller, S. ; Lenhard, M. ; Schuster, T. ; Nekljudova, V. ; Lebeau, A. ; Loibl, S. ; von Minckwitz, G.Annals of oncology, 2011-09, Vol.22 (9), p.1988-1998 [Periódico revisado por pares]Oxford: Elsevier LtdTexto completo disponível |